{"transactions":[{"id":4616759,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T20:01:45.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":23287,"derivative":{"exercise_price":0.46,"expiration_date":"2036-09-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-390520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743173/000119312526390520/ownership.xml","form_type":"4"}},{"id":1426478,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T23:26:01.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13287,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":10909},"source":{"system":"sec-edgar","filing":"0000950170-24-099625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024099625/ownership.xml","form_type":"4"}},{"id":1852057,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:51:42.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":2378,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-23-037750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123037750/doc4.xml","form_type":"4"}},{"id":2244541,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:44:44.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":23620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":57765,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":23620},"source":{"system":"sec-edgar","filing":"0001209191-22-034108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122034108/doc4.xml","form_type":"4"}},{"id":2680864,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T20:14:26.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":34145,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10935},"source":{"system":"sec-edgar","filing":"0001209191-21-038203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121038203/doc4.xml","form_type":"4"}},{"id":3084923,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-10T17:19:13.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The Option will become 100% vested and exercisable on July 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on July 8, 2021."}],"balance_after":23210,"derivative":{"exercise_price":3.73,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":753},"source":{"system":"sec-edgar","filing":"0001209191-20-042124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120042124/doc4.xml","form_type":"4"}},{"id":3123947,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-03T15:12:37.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":9137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":22457,"derivative":{"exercise_price":3.69,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":9137},"source":{"system":"sec-edgar","filing":"0001209191-20-033827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120033827/doc4.xml","form_type":"4"}},{"id":3365878,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-11-19T15:50:54.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":5000,"price":4.25,"value":21250.0,"ownership":{"direct":true},"balance_after":8524,"source":{"system":"sec-edgar","filing":"0001209191-19-057084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119057084/doc4.xml","form_type":"4"}},{"id":3502252,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-04T23:51:47.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":6912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 3, 2020 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13320,"derivative":{"exercise_price":5.04,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":6912},"source":{"system":"sec-edgar","filing":"0001209191-19-034585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119034585/doc4.xml","form_type":"4"}},{"id":3899951,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2018-06-08T23:56:00.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":6408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal installments occurring on the first, second and third anniversary of the date of grant."}],"balance_after":6408,"derivative":{"exercise_price":10.8,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":6408},"source":{"system":"sec-edgar","filing":"0001209191-18-036806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919118036806/doc4.xml","form_type":"4"}}]}